The Inflation Reduction Act (IRA) is setting new benchmarks for pharmaceutical pricing through Medicare's maximum…
Richard ChumbleyApril 1, 2025
Blog
The Research Hub Blog
Our thought leaders keep you up-to-date with the latest trends in RWE, HEOR, and market access.
The Evidence Base recently featured a 'deep dive' analysis of this ISPOR 2024 presentation. …
Richard ChumbleyJune 6, 2024
Tijana Ignjatovic, MA, PhD, Executive Director, Access & Pricing, applies the case study of Minjuvi…
Richard ChumbleyMay 31, 2024
Andy Surinach, Executive Director of RWE and Data Strategy, delves into recent breakthroughs in Parkinson's…
Richard ChumbleyApril 15, 2024
AMCP Nexus 2023, held recently in Orlando, Florida, hosted a forum for healthcare stakeholders to…
Richard ChumbleyNovember 2, 2023
Alexandra Sosinsky, our Director, Pharmacoepidemiology & Safety, offers her thoughts on FDA’s recent guidance regarding…
Richard ChumbleyOctober 11, 2023
Catherine Tak Piech argues that specialists and a plethora of new technologies are now well…
Casey FrushourJanuary 19, 2022
Want to keep up sith the latest RWE, HEOR, and market access trends?
Signup for our Newsletter
Headquarters:
HOBOKEN
111 River Street, Suite 1120
Hoboken, New Jersey 07030, US
